Similar Articles |
|
Nursing September 2011 Yantis & Velander |
Untangling enteral nutrition guidelines This article discusses the latest EN practice recommendations issued in 2009, with an emphasis on specific nursing applications and patient safety. |
American Journal of Nursing February 2012 Simons & Abdallah |
Bedside Assessment of Enteral Tube Placement: Aligning Practice with Evidence Since the flexible Levin tube was introduced in 1921, enteral feeding has become ubiquitous. From the out-set, nurses have been responsible for confirming the correct placement of enteral feeding tubes prior to their use for alimentation or medication administration. |
Nursing June 2010 Daniel A. Hussar |
New drugs 2010, part 2 In this article, you'll learn about 14 recently marketed new drugs. |
Nursing February 2010 Daniel A. Hussar |
New Drugs 2010, PART 1 In this article, you'll learn about 16 new drugs. |
Nursing June 2011 Daniel A. Hussar |
New Drugs 2011: Part 2 In this article, you'll learn about seven recently approved drugs, including: fingolimod hydrochloride, an oral drug indicated to treat patients with relapsing forms of multiple sclerosis. |
American Family Physician April 15, 2002 Ina Li |
Feeding Tubes in Patients with Severe Dementia Patients with advanced dementia are among the most challenging patients to care for. Health care professionals commonly rely on feeding tubes to supply nutrition to these severely demented patients. However, various studies have not shown use of feeding tubes to be effective... |
Nursing July 2008 Daniel A. Hussar |
New Drugs08, Part 2 Here, you'll learn about eight new drugs, including doripenem, maraviroc and ixabepilone. |
Nursing February 2009 Daniel A. Hussar |
New Drugs 09: Part 1 Learn about 10 new drugs, including nebivolol HCl, the newest beta-adrenergic blocking agent for hypertension. |
American Family Physician September 1, 2006 Gardiner & Dvorkin |
Promoting Medication Adherence in Children The problem of getting children to follow a treatment regimen is widespread and is frustrating for physicians. Having the child participate in devising the plan improves adherence. |
Nursing March 2012 Daniel A. Hussar |
New Drugs 2012: part I In this article, you'll learn about 11 recently approved drugs. |
American Journal of Nursing April 2011 |
Strategies for Feeding Patients with Dementia An overview of the difficulties associated with feeding those with dementia and suggestions for caregivers to help overcome these challenges. |
American Family Physician November 15, 2002 Cynthia M. Williams |
Using Medications Appropriately in Older Adults Finding the right balance between too few and too many drugs will help ensure increased longevity, improved overall health, and enhanced functioning and quality of life for the aging population. |
American Journal of Nursing June 2009 Prahlow et al. |
Case Study: Asphyxia Caused by Inspissated Oral and Nasopharyngeal Secretions This case serves to remind clinicians that a failure to provide good oral care and adequate hydration is not only poor practice but can result in death. |
American Journal of Nursing June 2009 Stein & Henry |
Poor Oral Hygiene in Long-Term Care The poor oral care given to vulnerable patients in long-term care settings can have serious consequences, including increased risk of stroke, heart disease, and pneumonia. |
American Family Physician October 1, 2000 |
Artificial Fluids and Nutrition When do people need artificial fluids and nutrition?... What is involved in artificial feeding?... What happens if artificial fluids or nutrition are not given?... What are the benefits?... What are the burdens?... |
Nursing August 2009 Regan & Dallachiesa |
How to care for a patient with a tracheostomy Patients with tracheostomies aren't limited to critical care settings and can be found in all nursing units. No matter where you work, you need a basic understanding of the nursing care required for these patients. |
IEEE Spectrum November 2009 Jeffrey T. Borenstein |
Flexible Microsystems Deliver Drugs Through the Ear A microelectromechanical systems-based microfluidic implant could open up many difficult-to-treat diseases to drug therapy |
Chemistry World May 26, 2011 Rebecca Brodie |
Nanospray for nanodrugs Teams from the US and Germany have developed a spray drying technique to fabricate drug formulations smaller than 100nm for pharmaceutical trials, improving the drugs' solubility, or bioavailability. |
Pharmaceutical Executive April 1, 2011 |
Off-Label But On Point? Use of off-label drugs is a balancing act for physicians, and poses even more problems for pharma. The FDA is moving slowly to help. |
BusinessWeek May 23, 2005 Carol Marie Cropper |
Counter Intelligence Nonprescription drugs can often be just as strong as prescription drugs; in fact, many of them used to be just that. So, to use over-the-counter drugs safely, educate yourself about dosage, possible interactions, and even ingredients. |
The Motley Fool September 28, 2010 Brian Orelli |
Don't Get Stuck! Invest in Needle-Free Drugs Here's how to make some money off society's general disdain for needles through next-generation drugs. |
Chemistry World November 2010 |
Column: In the Pipeline Should drug companies focus on big markets and the blockbuster dream? |
The Motley Fool January 12, 2010 Dayana Yochim |
6 Ways to Score Cheap(er) Drugs Stop overpaying for the pills you have to pop with these simple ways to trim your prescription-drug tab. |
The Motley Fool April 29, 2011 Brian Orelli |
Oral Multiple Sclerosis Drugs Heat Up Watch out Novartis and Gilenya. |
Chemistry World August 20, 2015 Andy Extance |
Porous pills could be largest industrial 3D printing use The first ever approval by the US Food and Drug Administration of a 3D printed tablet promises to make medications easier to swallow than existing formulations. |
American Family Physician June 15, 2002 Jeffrey L. Cummings |
Guidelines for Managing Alzheimer's Disease: Part II. Treatment Once the clinical diagnosis of Alzheimer's disease has been made, a treatment plan must be developed. Patient symptoms and care needs change as Alzheimer's disease progresses. |
Chemistry World April 2011 |
Molecular Obesity is Weighing Down Drug Discovery Medicinal chemistry's quest for potent drug candidates has resulted in molecules that are too large and too lipophilic for their own good. |
Chemistry World July 2009 Derek Lowe |
Column: In the pipeline The author wonders where we'd be without the formulation chemists |
BusinessWeek January 21, 2010 John Carey |
Making Personalized Medicine Pay Medco and other pharmacy benefit managers say future profits depend on matching drugs to patients based on their genes. |
The Motley Fool April 12, 2011 Brian Orelli |
How Significant Is 'Statistically Significant' for Biogen? Biogen could have a third multiple sclerosis blockbuster on its hands. |
American Journal of Nursing August 2008 Stockdell & Amella |
How to Try This: The Edinburgh Feeding Evaluation in Dementia Scale: Determining How Much Help People with Dementia Need at Mealtime. The Edinburgh Feeding Evaluation in Dementia scale is an 11-item instrument developed to assess eating and feeding problems in people with late-stage dementia. Using the scale, a nurse can identify a patient's needs and build an effective care plan. |
The Motley Fool May 26, 2011 Brian Orelli |
Congress Sets Bad Precedent With AVANIR What happened to free markets? |
The Motley Fool January 25, 2011 Brian Orelli |
2 Keys to Amgen's Continued Success Prolia and Xgeva have to perform. |
The Motley Fool June 7, 2011 Brian Orelli |
Sometimes a Partnership Feels Personal Merck and Roche hook up for a diagnostic drug deal. |
Chemistry World July 2010 Anna Lewcock |
Medicine made to measure Healthcare tailored to suit the genetic makeup of the patient is finally coming to fruition. |
The Motley Fool June 11, 2010 Brian Orelli |
25 to 0! Now That's a Ringing Endorsement Novartis flies through its advisory panel meeting nearly unscathed. |
The Motley Fool May 21, 2010 Brian Orelli |
And You Thought Biotech Was High-Risk, High-Reward Large clinical trials make cardiovascular drugs risky, but the rewards are there, too. |
The Motley Fool June 8, 2010 Brian Orelli |
Injecting Uncertainty Into the Multiple Sclerosis Market Novartis' oral MS drug could be a blockbuster -- if it can get past the FDA. |
The Motley Fool March 31, 2011 Brian Orelli |
Drug Warning Labels: The Good, Bad, and Ugly Once a drug is approved, investors can't fall asleep and ignore FDA announcements about drugs. They come in different varieties, but warnings tend to be of the bad and ugly variety more often than the good. |
American Journal of Nursing July 2009 Weinberg et al. |
Original Research: 'It Depends': Medical Residents' Perspectives on Working with Nurses We sought to determine the quality of the nurse-physician relationship by examining the communication and interaction between nurses and residents from the residents' perspective. |
The Motley Fool July 21, 2010 Brian Orelli |
Biogen Looks Good Now, but What About Tomorrow? Biogen Idec saw revenue increase 11% and adjusted earnings per share jump almost 75%, which is all well and good, but the longer-term prospects for the company aren't nearly as impressive. |
The Motley Fool July 12, 2010 Ryan McBride |
Synta Pharma CEO Trumpets New Top Cancer Drug Synta Pharmaceuticals has been climbing back from one of the Boston area's highest-profile clinical trial failures of 2009. |
The Motley Fool June 11, 2010 Brian Orelli |
Pfizer and Bristol Coagulate Against Clots Let's see how apixaban does against warfarin before we break out the "blockbuster" stamp. |
The Motley Fool December 2, 2010 Brian Orelli |
A Short FDA Delay. For What? GlaxoSmithKline and Valeant aren't saying. |
American Journal of Nursing May 2011 Pusateri et al. |
Original Research: The Role of the Non-ICU Staff Nurse on a Medical Emergency Team: Perceptions and Understanding We sought to determine the nursing staff's familiarity with and perceptions of the Medical Emergency Team at one hospital. |
The Motley Fool March 16, 2011 Brian Orelli |
Different Name, Same Great Results Incyte and Novartis' ruxolitinib passes another clinical trial. |
The Motley Fool January 29, 2010 Brian Orelli |
How to Make Billions of Dollars Without Really Trying Lackluster Alzheimer's drugs have been doing it for years. |
The Motley Fool February 8, 2011 Esterhuizen & Sellitti |
Battle of the Bulge: Biotech Takes on Obesity and Diabetes Will recent advances in pharmaceutical research revolutionize the weight loss industry? It's still early days, but here are some of the stocks to watch. |
American Journal of Nursing June 2011 Lisa M. Black |
Original Research: Tragedy into Policy: A Quantitative Study of Nurses' Attitudes Toward Patient Advocacy Activities In 2007 and 2008, 115 patients were found to be either certainly or presumptively infected with the hepatitis C virus through the reuse of contaminated medication vials at two southern Nevada endoscopy clinics. |
Chemistry World July 16, 2010 Matt Wilkinson |
Bittersweet victory for GSK's Avandia GlaxoSmithKline has received a muted 'thumbs up' from a US regulatory advisory panel for its much-maligned Type 2 diabetes drug Avandia (rosiglitazone), making it likely the US Food and Drug Administration will allow the UK-based pharma giant to continue selling the drug in the US. |